Europe’s drugmakers beat U.S. on access for poor
By Admin | June 21st, 2010 | Category: Top Stories | No Comments »Kate Kelland Reuters 06/20/2010 The Access to Medicines Index (AMI) — released this week for the second time since its launch in 2008 — is produced by a Dutch-based foundation and backed by 22 institutional investors and fund managers, who together manage $3.1 trillion in assets. It put Britain’s GlaxoSmithKline at the top of its list of 20 of the world’s largest pharmaceutical companies, ranked on the efforts to make sure medicines are made for, and reach, people in developing countries. The index is designed [...]

